Liraglutide ameliorates cognitive decline by promoting autophagy via the AMP-activated protein kinase/mammalian target of rapamycin pathway in a streptozotocin-induced mouse model of diabetes | |
Kong, Fei-Juan; Wu, Jia-Hua; Sun, Shui-Ya; Ma, Lei-Lei; Zhou, Jia-Qiang | |
刊名 | NEUROPHARMACOLOGY
![]() |
2018 | |
卷号 | 131 |
关键词 | Liraglutide Autophagy Diabetes Neuronal apoptosis Cognitive decline |
ISSN号 | 0028-3908 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3600350 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Kong, Fei-Juan,Wu, Jia-Hua,Sun, Shui-Ya,et al. Liraglutide ameliorates cognitive decline by promoting autophagy via the AMP-activated protein kinase/mammalian target of rapamycin pathway in a streptozotocin-induced mouse model of diabetes[J]. NEUROPHARMACOLOGY,2018,131. |
APA | Kong, Fei-Juan,Wu, Jia-Hua,Sun, Shui-Ya,Ma, Lei-Lei,&Zhou, Jia-Qiang.(2018).Liraglutide ameliorates cognitive decline by promoting autophagy via the AMP-activated protein kinase/mammalian target of rapamycin pathway in a streptozotocin-induced mouse model of diabetes.NEUROPHARMACOLOGY,131. |
MLA | Kong, Fei-Juan,et al."Liraglutide ameliorates cognitive decline by promoting autophagy via the AMP-activated protein kinase/mammalian target of rapamycin pathway in a streptozotocin-induced mouse model of diabetes".NEUROPHARMACOLOGY 131(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论